Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparan sulfate-glucosamine 3-sulfotransferase 4 (HS3ST4) is an enzyme that catalyzes the transfer of a sulfate group to the 3-O position of glucosamine residues in heparan sulfate chains, generating specific sulfated motifs used in cellular signaling and as attachment sites for herpesviruses. Expression of HS3ST4 is linked to viral entry and pathogenicity in herpes simplex and varicella-zoster viruses, and sequence variants in its gene have been associated with susceptibility to herpes zoster and postherpetic neuralgia
Not therapeutically targeted by approved drugs; potential mechanisms involve inhibition of enzymatic sulfotransferase activity or blockade of HS modification to prevent viral entry
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on heparan sulfate-glucosamine 3-sulfotransferase 4 (HS3ST4).